Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 23% ± 4% | |
| astrocyte | 7 studies | 33% ± 15% | |
| adipocyte | 6 studies | 21% ± 4% | |
| glutamatergic neuron | 4 studies | 53% ± 22% | |
| GABAergic neuron | 4 studies | 44% ± 18% | |
| oligodendrocyte precursor cell | 4 studies | 30% ± 10% | |
| oligodendrocyte | 4 studies | 28% ± 6% | |
| glycinergic amacrine cell | 3 studies | 24% ± 8% | |
| transit amplifying cell | 3 studies | 20% ± 6% | |
| interneuron | 3 studies | 41% ± 22% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 41% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 817.96 | 1445 / 1445 | 100% | 6.48 | 183 / 183 |
| prostate | 100% | 955.58 | 245 / 245 | 100% | 5.72 | 501 / 502 |
| lung | 100% | 771.68 | 576 / 578 | 100% | 4.63 | 1154 / 1155 |
| brain | 99% | 1003.69 | 2628 / 2642 | 100% | 4.09 | 705 / 705 |
| breast | 100% | 993.72 | 459 / 459 | 99% | 5.01 | 1109 / 1118 |
| thymus | 100% | 1032.99 | 653 / 653 | 98% | 3.77 | 595 / 605 |
| stomach | 100% | 709.99 | 359 / 359 | 98% | 5.36 | 281 / 286 |
| intestine | 100% | 1045.89 | 966 / 966 | 98% | 4.86 | 517 / 527 |
| bladder | 100% | 918.38 | 21 / 21 | 98% | 3.87 | 494 / 504 |
| uterus | 100% | 1104.93 | 170 / 170 | 98% | 3.89 | 448 / 459 |
| kidney | 100% | 735.35 | 89 / 89 | 98% | 4.52 | 879 / 901 |
| pancreas | 100% | 535.56 | 327 / 328 | 98% | 3.60 | 174 / 178 |
| ovary | 100% | 1061.27 | 180 / 180 | 97% | 3.27 | 419 / 430 |
| adrenal gland | 100% | 631.26 | 258 / 258 | 96% | 3.18 | 220 / 230 |
| skin | 100% | 953.53 | 1807 / 1809 | 88% | 3.51 | 415 / 472 |
| liver | 100% | 436.18 | 226 / 226 | 71% | 1.48 | 288 / 406 |
| adipose | 100% | 957.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 939.33 | 241 / 241 | 0% | 0 | 0 / 0 |
| muscle | 100% | 674.45 | 802 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 821.64 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 512.05 | 844 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 3.07 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 3.17 | 26 / 29 |
| eye | 0% | 0 | 0 / 0 | 60% | 1.72 | 48 / 80 |
| peripheral blood | 32% | 431.66 | 297 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045494 | Biological process | photoreceptor cell maintenance |
| GO_0016579 | Biological process | protein deubiquitination |
| GO_0006281 | Biological process | DNA repair |
| GO_0070911 | Biological process | global genome nucleotide-excision repair |
| GO_0006508 | Biological process | proteolysis |
| GO_0016477 | Biological process | cell migration |
| GO_0003407 | Biological process | neural retina development |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0001917 | Cellular component | photoreceptor inner segment |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
| Gene name | USP45 |
| Protein name | Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12) Ubiquitin specific peptidase 45 ubiquitinyl hydrolase 1 (EC 3.4.19.12) |
| Synonyms | hCG_17265 |
| Description | FUNCTION: Catalyzes the deubiquitination of SPDL1 . Plays a role in the repair of UV-induced DNA damage via deubiquitination of ERCC1, promoting its recruitment to DNA damage sites . May be involved in the maintenance of photoreceptor function . May play a role in normal retinal development (By similarity). Plays a role in cell migration . . FUNCTION: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes. . |
| Accessions | Q70EL2 ENST00000496090.6 E2QRF0 ENST00000511403.5 ENST00000327681.10 [Q70EL2-1] ENST00000500704.7 [Q70EL2-1] ENST00000507717.5 ENST00000369233.6 H0YA21 H0Y986 H0Y8J5 D6RC01 D6RE98 ENST00000506871.5 H0Y8Q0 ENST00000508908.1 ENST00000329966.10 ENST00000472914.6 D6RBV3 ENST00000496518.6 |